CTL019 Out of Specification MAP for ALL or DLBCL Patients
NCT ID: NCT03601442
Last Updated: 2025-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
AVAILABLE
EXPANDED_ACCESS
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Lymphodepletion to Improve Outcomes in Patients Receiving Cell Therapy With Kymriah
NCT06003179
Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL): Inpatient and Outpatient Settings
NCT05918809
Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma
NCT02031419
Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139)
NCT02038933
Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT05338892
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CTL019
CTL019
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Patients must be treated at a healthcare facility that has been certified /qualified by Novartis to dispense and administer tisagenlecleucel in line with the tisagenlecleucel Risk Evaluation and Mitigation Strategy (REMS) in the United States (US) or the local Risk Management Plan (RMP).
\- Note that tisagenlecleucel treatment should be initiated under the direction of and supervised by a HCP experienced in the treatment of hematological malignancies and trained for administration and management of patients treated with tisagenlecleucel. The healthcare facility must have tocilizumab for use in the event of cytokine release syndrome and emergency equipment per patient prior to infusion on site and ensure timely access to additional doses of tocilizumab; for detailed requirements refer to the approved local label.
2. Patients must be prescribed tisagenlecleucel in line with the locally approved indications (for the precise indication statements see approved local product label). These may include:
* pediatric and young adult patients up to and (including) 25 years of age with refractory/relapsed (r/r) acute lymphoblastic leukemia (B-ALL)
* adult patients with r/r diffuse large B-cell lymphoma (DLBCL)
3. Informed consent must be obtained prior to treatment
4. The incoming apheresis material and/or the final manufactured product is out of specification due to failure to meet acceptance or release specifications
Exclusion Criteria
1\. Contraindications as per the approved local label or the IB.
1 Day
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Banner MDACC
Gilbert, Arizona, United States
University of Arizona Cancer Center
Phoenix, Arizona, United States
Banner University of Arizona Medical Center
Phoenix, Arizona, United States
Phoenix Children's Hospital
Phoenix, Arizona, United States
Phoenix Childrens Hospital
Phoenix, Arizona, United States
Banner Uni Medical Center Tucson
Tucson, Arizona, United States
City of Hope National Medical Center Hematology&HematCellTransplant
Duarte, California, United States
City of Hope
Duarte, California, United States
Children's Hospital Los Angeles CRFB002H2301
Los Angeles, California, United States
Children's Hospital Los Angeles
Los Angeles, California, United States
Childrens Hospital Los Angeles
Los Angeles, California, United States
Mattel Childrens Hospital UCLA
Los Angeles, California, United States
University of California at Los Angeles UCLA
Los Angeles, California, United States
Lucile Packard Children s Hospital Stanford University
Palo Alto, California, United States
Lucile Packard Childrens Hospital
Palo Alto, California, United States
Stanford University Medical Center
Palo Alto, California, United States
UC San Diego
San Diego, California, United States
University of California at San Diego, Moores Cancer Ctr UCSD
San Diego, California, United States
Rady Children s Hospital Dept of Oncology
San Diego, California, United States
Rady Childrens Hospital
San Diego, California, United States
Ucsf Benioff Childrens Hospital Pediatric Hematology Oncology
San Francisco, California, United States
University of Califronia San Francisco
San Francisco, California, United States
University of California, Los Angeles
Santa Monica, California, United States
Stanford Healthcare
Stanford, California, United States
Children's Hospital Colorado
Denver, Colorado, United States
Yale Cancer Center
New Haven, Connecticut, United States
University of Miami Hospital
Miami, Florida, United States
JHMI All Children s Hospital
St. Petersburg, Florida, United States
Emory University School of Medicine Emory University (12)
Atlanta, Georgia, United States
Emory University School of Medicine/Winship Cancer Institute Winship Cancer Center
Atlanta, Georgia, United States
Emory University School of Medicine/Winship Cancer Institute
Atlanta, Georgia, United States
Children's Healthcare of Atlanta Cellular Therapies Lab
Atlanta, Georgia, United States
Northside Hospital
Atlanta, Georgia, United States
Ann and Robert H Lurie Childrens Hospital of Chicago
Chicago, Illinois, United States
Northwestern
Chicago, Illinois, United States
University of Illinois at Chicago
Chicago, Illinois, United States
University of CHicago Comer Children's Hospital Regulatory
Chicago, Illinois, United States
University of Chicago
Chicago, Illinois, United States
Healthwatch Plaza Research Associates
Louisville, Kentucky, United States
University of Maryland Medical Center UMMC
Baltimore, Maryland, United States
University of Maryland Medical Center
Baltimore, Maryland, United States
University of Maryland
Baltimore, Maryland, United States
Johns Hopkins Outpatient Center
Baltimore, Maryland, United States
Johns Hopkins University Hospital
Baltimore, Maryland, United States
Tufts Medical Center
Boston, Massachusetts, United States
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
Massachusetts General Hospital DF/HCC institutions
Boston, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
MGH Cancer Center MGH Cancer Center
Boston, Massachusetts, United States
MGH Cancer Center
Boston, Massachusetts, United States
Dana Farber Cancer Institute Dana Farber Cancer Institute
Boston, Massachusetts, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
University of Michigan IRB
Ann Arbor, Michigan, United States
University of Michigan Medical Center
Ann Arbor, Michigan, United States
University of Michigan Health System
Ann Arbor, Michigan, United States
Karmanos Cancer Institute
Detroit, Michigan, United States
Moffitt Cancer Center
Detroit, Michigan, United States
Wayne State University - Karmanos Cancer Institute
Detroit, Michigan, United States
Henry Ford Hospital Henry Ford
Detroit, Michigan, United States
University of Minnesota Masonic Childrens Hospital
Minneapolis, Minnesota, United States
University of Minnesota
Minneapolis, Minnesota, United States
Mayo CLinic
Rochester, Minnesota, United States
WUSTL Jewish Barnes
St Louis, Missouri, United States
Hackensack University Medical Center Hackensack UMC
Hackensack, New Jersey, United States
Hackensack University Medical Center Onc Dept
Hackensack, New Jersey, United States
Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Roswell Park Cancer Institute Rosewell
Buffalo, New York, United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Memorial Sloan Kettering
New York, New York, United States
Memorial Sloan Kettering Cancer Center MSKCC
New York, New York, United States
Memorial Sloan Kettering Cancer Center Oncology
New York, New York, United States
Columbia University Medical Center New York Presbyterian CUMC Research Pharmacy
New York, New York, United States
Columbia University Medical Center New York Presbyterian Neuroendocrine Unit
New York, New York, United States
Memorial Sloan Kettering Cancer Center MSKCC (9)
New York, New York, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
University of North Carolina Chapel Hill Physician Office Building
Chapel Hill, North Carolina, United States
University of North Carolina Health System
Chapel Hill, North Carolina, United States
Atrium Heath
Charlotte, North Carolina, United States
Duke University Medical Center Dept. of DUMC (4)
Durham, North Carolina, United States
Duke University Medical Center
Durham, North Carolina, United States
Cincinnati Children s Hospital Medical Center
Cincinnati, Ohio, United States
Cincinnati Childrens Hospital
Cincinnati, Ohio, United States
Oncology Hematology Care Inc Drug Shipment
Cincinnati, Ohio, United States
University Hospitals Cleveland Medical Center Univ. Hospitals of Cleveland
Cleveland, Ohio, United States
Nationwide Childrens Hospital Center
Columbus, Ohio, United States
OSU Wexner MC James CH
Columbus, Ohio, United States
The Ohio State University Hospitals Clinic The Ohio State University
Columbus, Ohio, United States
The Ohio State University Hospitals Clinic
Columbus, Ohio, United States
The Ohio State University Regulatory
Columbus, Ohio, United States
The Ohio State University Comprehensive Cancer Center Ohio State UMC James Cancer Ct
Columbus, Ohio, United States
Hematology Oncology Center, Inc.
Elyria, Ohio, United States
Oregon Health Sciences University
Portland, Oregon, United States
Oregon Health and Science University
Portland, Oregon, United States
OHSU
Portland, Oregon, United States
Oregon Health and Science University
Portland, Oregon, United States
Childrens Hospital of Philadelphia CTRB 3006
Philadelphia, Pennsylvania, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Children's Hospital of Philadelphia Children's Hospital Of Phil(2)
Philadelphia, Pennsylvania, United States
Children s Hospital of Philadelphia Patient Treatment
Philadelphia, Pennsylvania, United States
Children s Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
The Childrens Hospital of Philadelphia Children's Hosp Philadelphia
Philadelphia, Pennsylvania, United States
The Childrens Hospital of Philadelphia Pediatric Oncology/Stem Cell T
Philadelphia, Pennsylvania, United States
The Childrens Hospital of Philadelphia Regulatory
Philadelphia, Pennsylvania, United States
University of Pennsylvania Health System CERL080AUS90
Philadelphia, Pennsylvania, United States
Pennsylvania Oncology/Hemotology Dept.ofPenn. Onc./Hem.
Philadelphia, Pennsylvania, United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, United States
Medical University of South Carolina MUSC
Charleston, South Carolina, United States
Prisma Health Cancer Institute
Greenville, South Carolina, United States
Avera McKennan Hospital and University Health Center
Sioux Falls, South Dakota, United States
Methodist University Hospital Blood and Marrow Transplant
Memphis, Tennessee, United States
Texas Cancer Center ( Medical City Dallas Hospital) TX Cancer Center
Dallas, Texas, United States
Univof Texas Southwestern Medical Center, Dept of Pediatrics
Dallas, Texas, United States
U of TX Southwestern Medical Center - SimmonsCompCancerCtr Satellite
Dallas, Texas, United States
UT Southwestern Medical Center Pediatric Hematology/Onc
Dallas, Texas, United States
UT Southwestern Medical Center UT SW Medical Ctr of Dallas
Dallas, Texas, United States
Cook Children's
Fort Worth, Texas, United States
Texas Children's Hospital Baylor College of Medicine
Houston, Texas, United States
Baylor College of Medicine
Houston, Texas, United States
Houston Methodist Cancer Center Methodist Cancer Center (2)
Houston, Texas, United States
Houston Methodist Hospital
Houston, Texas, United States
MD Anderson Cancer Center/University of Texas MDACC
Houston, Texas, United States
MD Anderson Cancer Center/University of Texas StudyCoordinator:CTKI258A2102
Houston, Texas, United States
MD Anderson Cancer Center
Houston, Texas, United States
Methodist Hospital / Methodist Cancer Center Houston Methodist Hospital
Houston, Texas, United States
Methodist Healthcare System
San Antonio, Texas, United States
Methodist Hospital
San Antonio, Texas, United States
University of Utah / Huntsman Cancer Institute Huntsman Cancer Cente
Salt Lake City, Utah, United States
Primary Childrens Medical Center Oncology
Salt Lake City, Utah, United States
LDS Hospital
Salt Lake City, Utah, United States
University of Virginia Health Systems UVA
Charlottesville, Virginia, United States
VCU Health Systems, MCV
Richmond, Virginia, United States
Fred Hutchinson Cancer Research Center Dept. of FHCRC
Seattle, Washington, United States
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
University of Wisconsin Hospital and Clinics Hematopoietic Stem Cell Lab
Madison, Wisconsin, United States
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
University Wisconsin Children's Hospital
Madison, Wisconsin, United States
Childrens Hospital of Wisconsin
Milwaukee, Wisconsin, United States
Medical College of Wisconsin Med College of WI (29)
Milwaukee, Wisconsin, United States
Novartis Investigative Site
Murdoch, Western Australia, Australia
Novartis Investigative Site
Toronto, Ontario, Canada
Novartis Investigative Site
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
MAP requests are initiated by a licensed physician.https:// www.novart is.com/healthcare-professionals/managed-access-programs
Role: CONTACT
Novartis Pharmaceuticals
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCTL019B2003I
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.